Questions we get asked most often.
What stage of development are you at?
We are currently improving our existing prototype. We have prototypes of a mechanical measuring device and 3D-printed vaginal pessaries. Clinical validation is underway with partners at KBC Zagreb.
When do you plan commercial use?
The timeline depends on the regulatory process (Class IIb medical devices). We estimate 12 to 24 months to first clinical use, but the date may shift depending on validation results.
Are you open to investment?
Yes. We are currently interested in pre-seed and seed investment specialised in MedTech or impact investing. Write to us at info@permedis.com marked "Investor".
Which kinds of partnership interest you most?
Clinical partners for validation, academic researchers for joint development, and industrial partners for scaling production. We are open to all serious enquiries.
Do you only work in gynaecology?
No, we work in other fields too. Gynaecology (pelvic organ prolapse) is our entry segment, but the technology applies to a broad range of personalised medical devices, and our vision includes expanding to other specialisms for all patients, regardless of sex.
Can I contact you as a patient?
Not directly. Our product is B2B and goes through doctors and specialists. If you're interested in our technology as a patient, get in touch and we'll refer you to the right clinical partner when we're ready.
Have an idea or challenge?
Send us an enquiry and we'll get back with a timeline and approximate price within 48 hours.